<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>SUMAXIN TS- sulfacetamide sodium and sulfur lotion </strong><br>Medimetriks Pharmaceuticals, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Sumaxin (sodium sulfacetamide 8% and sulfur 4%) TS</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<p class="First"><span class="Bold">DESCRIPTION:</span> Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl] acetamide, monosodium salt, monohydrate. The structural formula is: <br></p>
<p><img alt="structure SS" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2e3350eb-ca10-4bf2-819f-3eb46c7437b7&amp;name=structure.jpg"></p>
<p>Each mL of <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> contains 90 mg of sodium sulfacetamide and 40 mg of sulfur in a formulation consisting of: aloe, butylated hydroxytoluene, cetyl alcohol, disodium oleamido MEA sulfosuccinate, edetate disodium, fragrance, glyceryl stearate/PEG-100 stearate, green tea, magnesium aluminum silicate, methylparaben, propylparaben, purified water, sodium cocoyl isethionate, sodium methyl cocoyl taurate, sodium thiosulfate, stearyl alcohol, xanthan gum. <br><br>Each mL of <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS </span>contains 80 mg of sodium sulfacetamide and 40 mg of sulfur in a formulation consisting of: aloe, butylated hydroxytoluene, cetyl alcohol, disodium oleamido MEA sulfosuccinate, edetate disodium, fragrance, glyceryl stearate, green tea, magnesium aluminum silicate, methylparaben, PEG-100 stearate, propylparaben, purified water, sodium cocoyl isethionate, sodium methyl cocoyl taurate, sodium thiosulfate, stearyl alcohol, xanthan gum. <br></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<p class="First"><span class="Bold">CLINICAL PHARMACOLOGY:</span> The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. <br><br>While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> is unknown, but it has been reported that it inhibits the growth of Propionibacterium <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span> and the formation of free fatty acids. <br></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<p class="First"><span class="Bold">INDICATIONS:</span><span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> and <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span> are indicated for the topical control of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>, <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> <span class="product-label-link" type="condition" conceptid="136773" conceptname="Rosacea">rosacea</span> and <span class="product-label-link" type="condition" conceptid="137053" conceptname="Seborrheic dermatitis">seborrheic dermatitis</span>. <br></p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<p class="First"><span class="Bold">CONTRAINDICATIONS: Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash </span>and <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span> are contraindicated for use by patients having known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sulfonamides, sulfur or any other component of this preparation. <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> and <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span> are not to be used by patients with kidney disease.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<p class="First"><span class="Bold">WARNINGS:</span> Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to topical sulfonamides. Systemic toxic reactions such as <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">acute hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="4047773" conceptname="Purpura">purpura</span> hemorrhagica, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">drug fever</span>, <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span>, and <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span> indicate <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved. <br><br><span class="Bold">FOR EXTERNAL USE ONLY.</span> Keep away from eyes. Keep out of reach of children. Keep container tightly closed. <br></p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<p class="First"><span class="Bold">PRECAUTIONS:</span> General – If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve <span class="product-label-link" type="condition" conceptid="135029" conceptname="Peeling of skin">desquamation</span> without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>, but patients should be cautioned about the possibility. <br><br></p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7"></a><p></p>
<p class="First">Information for Patients – Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician. <br></p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-8"></a><p></p>
<p class="First">Carcinogenesis, Mutagenesis and Impairment of Fertility – Long-term studies in animals have not been performed to evaluate carcinogenic potential. <br></p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-9"></a><p></p>
<p class="First"><span class="Bold">PREGNANCY:</span> Category C – Animal reproduction studies have not been conducted with <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> and <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span>. It is also not known whether <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> and <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span> can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> and<span class="Bold"> Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span> should be given to a pregnant woman only if clearly needed. <br></p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-10"></a><p></p>
<p class="First"><span class="Bold">NURSING MOTHERS:</span> It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> and <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span>. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> and <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span> are administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-11"></a><p></p>
<p class="First"><span class="Bold">PEDIATRIC USE:</span> Safety and effectiveness in children under the age of 12 have not been established.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-12"></a><p></p>
<p class="First"><span class="Bold">ADVERSE REACTIONS:</span> Although rare, sodium sulfacetamide may cause local irritation. <br></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-13"></a><p></p>
<p class="First"><span class="Bold">DOSAGE AND ADMINISTRATION:</span> Apply <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> or <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS </span>once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off <span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash</span> or <span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS</span> sooner or using less often.  <br></p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-14"></a><p></p>
<p class="First"><span class="Bold">HOW SUPPLIED:</span><span class="Bold">Sumaxin® (sodium sulfacetamide 9% and sulfur 4%) Wash </span>is available in a 16 fl. oz. (473 mL) bottle, NDC 43538-130-16. <br><br><span class="Bold">Sumaxin® (sodium sulfacetamide 8% and sulfur 4%) TS </span>is available in a 16 fl. oz. (473 mL) bottle, NDC 43538-160-16. <br><br><br></p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="section-15"></a><p></p>
<p class="First">Store at controlled room temperature 15°-30° C (59°-86° F). Protect from freezing. <br><br><span class="Bold">KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. </span><br><br></p>Manufactured for: <br><br>MEDIMETRIKS<br>PHARMACEUTICALS, INC.<br><br> 363 Route 46 West <br>Fairfield, NJ 07004-2402 USA <br><br>www.medimetriks.com <br><br><br>Manufactured by: <br>Groupe PARIMA, Inc. <br>Montreal, QC H4S 1X6 CANADA <br><p><br></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-16"></a><p></p>
<br><p class="First"><img alt="label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2e3350eb-ca10-4bf2-819f-3eb46c7437b7&amp;name=label.jpg"></p>
<p><img alt="carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=2e3350eb-ca10-4bf2-819f-3eb46c7437b7&amp;name=carton.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>SUMAXIN 		
					TS</strong><br><span class="contentTableReg">sodium sulfacetamide and sulfur lotion</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:43538-160</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SULFACETAMIDE SODIUM</strong> (SULFACETAMIDE) </td>
<td class="formItem">SULFACETAMIDE SODIUM</td>
<td class="formItem">80 mg  in 1 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SULFUR</strong> (SULFUR) </td>
<td class="formItem">SULFUR</td>
<td class="formItem">40 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALOE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CETYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>DISODIUM OLEAMIDO MEA-SULFOSUCCINATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>EDETATE DISODIUM</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>GLYCERYL MONOSTEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GREEN TEA LEAF</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM ALUMINUM SILICATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>METHYLPARABEN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYOXYL 100 STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PROPYLPARABEN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM COCOYL ISETHIONATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM THIOSULFATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:43538-160-16</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">473 mL in 1 BOTTLE, PUMP</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">09/02/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Medimetriks Pharmaceuticals, Inc.
							(019903816)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Groupe PARIMA, Inc. (252437850)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Groupe PARIMA, Inc.</td>
<td class="formItem"></td>
<td class="formItem">252437850</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>9d10a158-2a1f-4a26-b0c9-f6964eef0e58</div>
<div>Set id: 2e3350eb-ca10-4bf2-819f-3eb46c7437b7</div>
<div>Version: 1</div>
<div>Effective Time: 20100902</div>
</div>
</div> <div class="DistributorName">Medimetriks Pharmaceuticals, Inc.</div></p>
</body></html>
